A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
Clinical trial NCT03089944 · COMPLETED
Trial details
- NCT number
- NCT03089944
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2019-07-31
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.